PANAGORA ASSET MANAGEMENT INC - CHEMOCENTRYX INC ownership

CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 195 filers reported holding CHEMOCENTRYX INC in Q4 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.

Quarter-by-quarter ownership
PANAGORA ASSET MANAGEMENT INC ownership history of CHEMOCENTRYX INC
ValueSharesWeighting
Q2 2022$1,287,000
+80.5%
51,929
+82.6%
0.01%
+100.0%
Q1 2022$713,000
-12.3%
28,434
+27.3%
0.00%0.0%
Q4 2021$813,000
+163.1%
22,336
+23.5%
0.00%
+100.0%
Q3 2021$309,000
+27.7%
18,0800.0%0.00%
+100.0%
Q2 2021$242,000
-79.0%
18,080
-19.5%
0.00%
-83.3%
Q1 2021$1,151,000
-26.6%
22,463
-11.4%
0.01%
-33.3%
Q4 2020$1,569,000
+12.9%
25,342
-0.1%
0.01%0.0%
Q3 2020$1,390,000
-75.4%
25,368
-74.2%
0.01%
-75.0%
Q2 2020$5,659,000
+67.3%
98,367
+16.8%
0.04%
+50.0%
Q1 2020$3,383,000
-79.2%
84,198
-79.5%
0.02%
-67.6%
Q4 2019$16,279,000
+513.1%
411,609
+5.1%
0.07%
+516.7%
Q3 2019$2,655,000
-29.6%
391,651
-3.4%
0.01%
-29.4%
Q2 2019$3,773,000
-12.1%
405,643
+31.3%
0.02%
-10.5%
Q1 2019$4,290,000
+21.3%
308,857
-4.7%
0.02%
+18.8%
Q4 2018$3,537,000
-13.7%
324,223
+0.0%
0.02%
+6.7%
Q3 2018$4,097,000
-5.1%
324,114
-1.1%
0.02%
-11.8%
Q2 2018$4,318,000
-14.2%
327,866
-11.4%
0.02%
-15.0%
Q1 2018$5,031,000
+199.1%
369,959
+30.9%
0.02%
+233.3%
Q4 2017$1,682,000
-15.0%
282,638
+6.0%
0.01%
-25.0%
Q3 2017$1,978,000
+3.1%
266,518
+30.1%
0.01%0.0%
Q2 2017$1,918,000
+71.2%
204,908
+33.2%
0.01%
+60.0%
Q1 2017$1,120,000
+220.0%
153,808
+225.5%
0.01%
+150.0%
Q4 2016$350,000
+960.6%
47,254
+1061.9%
0.00%
Q2 2015$33,0004,0670.00%
Other shareholders
CHEMOCENTRYX INC shareholders Q4 2021
NameSharesValueWeighting ↓
Tri Locum Partners LP 276,400$4,726,0001.88%
TANG CAPITAL MANAGEMENT LLC 500,000$8,550,0001.78%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 94,300$7,131,0001.72%
Integral Health Asset Management, LLC 300,000$5,130,0001.48%
SILVERARC CAPITAL MANAGEMENT, LLC 139,200$2,380,0001.35%
MANGROVE PARTNERS IM, LLC 686,300$11,736,0001.05%
Ikarian Capital, LLC 600,000$10,261,0000.72%
Ikarian Capital, LLC 600,000$10,260,0000.72%
Sofinnova Investments, Inc. 517,708$8,853,0000.52%
Birchview Capital, LP 25,000$428,0000.29%
View complete list of CHEMOCENTRYX INC shareholders